Russell Investments Group
VIVO

Russell Investments Group’s Meridian Bioscience Inc VIVO Stock Holding History

Russell Investments Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,091
Closed -$302K – 3442
2022
Q4 		$302K Sell
9,091
-2,623
-22% -$84.5K ﹤0.01% 2458
2022
Q3 		$369K Sell
11,714
-2,067
-15% -$66.9K ﹤0.01% 2352
2022
Q2 		$419K Hold
13,781
– – ﹤0.01% 2328
2022
Q1 		$357K Buy
+13,781
New +$328K ﹤0.01% 2325
2021
Q3 		– Sell
-42,314
Closed -$937K – 3274
2021
Q2 		$937K Sell
42,314
-2,214
-5% -$47K ﹤0.01% 2340
2021
Q1 		$1.17M Buy
44,528
+30,328
+214% +$721K ﹤0.01% 2178
2020
Q4 		$265K Sell
14,200
-86,604
-86% -$1.62M ﹤0.01% 2670
2020
Q3 		$1.73M Sell
100,804
-79,656
-44% -$1.55M ﹤0.01% 1776
2020
Q2 		$4.07M Sell
180,460
-83,946
-32% -$1.22M 0.01% 1222
2020
Q1 		$2.19M Sell
264,406
-29,287
-10% -$247K 0.01% 1423
2019
Q4 		$2.86M Buy
293,693
+152,637
+108% +$1.43M 0.01% 1533
2019
Q3 		$1.34M Buy
141,056
+114,156
+424% +$1.2M ﹤0.01% 1869
2019
Q2 		$315K Buy
26,900
+24,068
+850% +$290K ﹤0.01% 2408
2019
Q1 		$50K Sell
2,832
-16,435
-85% -$273K ﹤0.01% 2804
2018
Q4 		$333K Sell
19,267
-10,595
-35% -$181K ﹤0.01% 2453
2018
Q3 		$445K Sell
29,862
-50,733
-63% -$787K ﹤0.01% 2440
2018
Q2 		$1.28M Buy
80,595
+22,867
+40% +$341K ﹤0.01% 1983
2018
Q1 		$819K Sell
57,728
-23,121
-29% -$342K ﹤0.01% 2290
2017
Q4 		$1.14M Buy
80,849
+26,993
+50% +$395K ﹤0.01% 2089
2017
Q3 		$770K Buy
53,856
+14,184
+36% +$203K ﹤0.01% 2264
2017
Q2 		$625K Buy
39,672
+8,954
+29% +$129K ﹤0.01% 2333
2017
Q1 		$424K Sell
30,718
-2,515
-8% -$35.2K ﹤0.01% 2483
2016
Q4 		$592K Buy
+33,233
New +$584K ﹤0.01% 2405

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Russell Investments Group's VIVO Position: Q1 2023 in Review

Russell Investments Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 9,091 shares — an estimated $302K sold.

Russell Investments Group first reported a position in VIVO in Q4 2016 and held it in 23 quarters. The position peaked at $4.07M in Q2 2020. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Russell Investments Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Russell Investments Group sold 9,091 Meridian Bioscience Inc shares in Q1 2023, an estimated $302K.
  • Russell Investments Group first reported a position in Meridian Bioscience Inc in Q4 2016 and held it in 23 quarters.
  • Russell Investments Group's Meridian Bioscience Inc position peaked at $4.07M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Russell Investments Group's 13F filing for Q1 2023, filed 9 May 2023.